The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients
Open accessAbstract
Lung disease is the leading cause of morbidity and mortality in cystic fibrosis (CF) patients. A modest number of bacterial pathogens have been correlated with pulmonary function decline; however, microbiological and molecular evidence suggests that CF airway infection is polymicrobial. To obtain a more complete assessment of the microbial community composition and dynamics, we undertook a longitudinal study by using culture-independent and microbiological approaches. In the process, we demonstrated that within complex and dynamic communities, the Streptococcus milleri group (SMG) can establish chronic pulmonary infections and at the onset of 39% of acute pulmonary exacerbations, SMG is the numerically dominant pathogen. We report the comprehensive polymicrobial community dynamics of a CF lung infection in a clinically relevant context. If a given organism, such as Pseudomonas aeruginosa , becomes resistant to antibiotic therapy, an alternative treatment avenue may mediate the desired clinical response by effectively managing the composition of the microbial community.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
Ecological Diversity and Its Measurement
Magurran, A. E. (1988) · Springer eBooks · doi:10.1007/978-94-015-7358-0 · Cited by 10,879
Liu, W. T., Marsh, T. L., Cheng, H., & Forney, L. J. (1997) · Applied and Environmental Microbiology · doi:10.1128/aem.63.11.4516-4522.1997 · Cited by 2,251
Lung Infections Associated with Cystic Fibrosis
Lyczak, J. B., Cannon, C. L., & Pier, G. B. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.194-222.2002 · Cited by 1,628
Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients
Smith, E. E., Buckley, D. G., Wu, Z., Saenphimmachak, C., Hoffman, L. R., D’Argenio, D. A., Miller, S. I., Ramsey, B. W., Speert, D. P., Moskowitz, S. M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602138103 · Cited by 1,319
Matsui, H., Grubb, B. R., Tarran, R., Randell, S. H., Gatzy, J. T., Davis, C. W., & Boucher, R. C. (1998) · Cell · doi:10.1016/s0092-8674(00)81724-9 · Cited by 1,169
Human β-Defensin-1 Is a Salt-Sensitive Antibiotic in Lung That Is Inactivated in Cystic Fibrosis
Goldman, M. J., Anderson, G. M., Stolzenberg, E. D., Kari, U. P., Zasloff, M., & Wilson, J. M. (1997) · Cell · doi:10.1016/s0092-8674(00)81895-4 · Cited by 1,080
Cystic Fibrosis Airway Epithelia Fail to Kill Bacteria Because of Abnormal Airway Surface Fluid
Smith, J. J., Travis, S. M., Greenberg, E. P., & Welsh, M. J. (1996) · Cell · doi:10.1016/s0092-8674(00)81099-5 · Cited by 1,039
Cited by
Segata, N., Haake, S. K., Mannon, P., Lemon, K. P., Waldron, L., Gevers, D., Huttenhower, C., & Izard, J. (2012) · Genome Biology · doi:10.1186/gb-2012-13-6-r42 · Cited by 1,076
The Microbiome and the Respiratory Tract
Dickson, R. P., Erb-Downward, J. R., Martinez, F. J., & Huffnagle, G. B. (2016) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021115-105238 · Cited by 953
The Changing Microbial Epidemiology in Cystic Fibrosis
LiPuma, J. J. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00068-09 · Cited by 806
Decade-long bacterial community dynamics in cystic fibrosis airways
Zhao, J., Schloss, P. D., Kalikin, L. M., Carmody, L. A., Foster, B. K., Petrosino, J. F., Cavalcoli, J. D., VanDevanter, D. R., Murray, S., Li, J. Z., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120577109 · Cited by 599
Pseudomonas aeruginosa Biofilms in Disease
Mulcahy, L. R., Isabella, V. M., & Lewis, K. (2014) · Microbial Ecology · doi:10.1007/s00248-013-0297-x · Cited by 518
Biofilm-Specific Antibiotic Resistance
Mah, T.-F. (2012) · Future Microbiology · doi:10.2217/fmb.12.76 · Cited by 504
The role of the microbiome in exacerbations of chronic lung diseases
Dickson, R. P., Martinez, F. J., & Huffnagle, G. B. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61136-3 · Cited by 495
Treatment of lung infection in patients with cystic fibrosis: Current and future strategies
Döring, G., Flume, P., Heijerman, H., & Elborn, J. S. (2012) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2012.10.004 · Cited by 474
Airway Microbiota and Pathogen Abundance in Age-Stratified Cystic Fibrosis Patients
Cox, M. J., Allgaier, M., Taylor, B., Baek, M. S., Huang, Y. J., Daly, R. A., Karaoz, U., Andersen, G. L., Brown, R., Fujimura, K. E., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011044 · Cited by 451
The role of the bacterial microbiome in lung disease
Dickson, R. P., Erb-Downward, J. R., & Huffnagle, G. B. (2013) · Expert Review of Respiratory Medicine · doi:10.1586/ers.13.24 · Cited by 419
Clinical Significance of Microbial Infection and Adaptation in Cystic Fibrosis
Hauser, A. R., Jain, M., Bar-Meir, M., & McColley, S. A. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00036-10 · Cited by 411
Role of the gut microbiota in defining human health
Fujimura, K. E., Slusher, N. A., Cabana, M. D., & Lynch, S. V. (2010) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.10.14 · Cited by 407
Lung microbiota across age and disease stage in cystic fibrosis
Coburn, B., Wang, P. W., Diaz Caballero, J., Clark, S. T., Brahma, V., Donaldson, S., Zhang, Y., Surendra, A., Gong, Y., Elizabeth Tullis, D., et al. (2015) · Scientific Reports · doi:10.1038/srep10241 · Cited by 395
Oral Microbiota Community Dynamics Associated With Oral Squamous Cell Carcinoma Staging
Yang, C.-Y., Yeh, Y.-M., Yu, H.-Y., Chin, C.-Y., Hsu, C.-W., Liu, H., Huang, P.-J., Hu, S.-N., Liao, C.-T., Chang, K.-P., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00862 · Cited by 369
Parallel bacterial evolution within multiple patients identifies candidate pathogenicity genes
Lieberman, T. D., Michel, J.-B., Aingaran, M., Potter-Bynoe, G., Roux, D., Davis, M. R., Skurnik, D., Leiby, N., LiPuma, J. J., Goldberg, J. B., et al. (2011) · Nature Genetics · doi:10.1038/ng.997 · Cited by 365
Fodor, A. A., Klem, E. R., Gilpin, D. F., Elborn, J. S., Boucher, R. C., Tunney, M. M., & Wolfgang, M. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045001 · Cited by 353
Delhaes, L., Monchy, S., Fréalle, E., Hubans, C., Salleron, J., Leroy, S., Prevotat, A., Wallet, F., Wallaert, B., Dei-Cas, E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036313 · Cited by 347
Filkins, L. M., Graber, J. A., Olson, D. G., Dolben, E. L., Lynd, L. R., Bhuju, S., & O'Toole, G. A. (2015) · Journal of Bacteriology · doi:10.1128/jb.00059-15 · Cited by 346
Tunney, M. M., Einarsson, G. G., Wei, L., Drain, M., Klem, E. R., Cardwell, C., Ennis, M., Boucher, R. C., Wolfgang, M. C., & Elborn, J. S. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201210-1937oc · Cited by 316
Candida Species Biofilms’ Antifungal Resistance
Silva, S., Rodrigues, C., Araújo, D., Rodrigues, M., & Henriques, M. (2017) · Journal of Fungi · doi:10.3390/jof3010008 · Cited by 302
Partitioning core and satellite taxa from within cystic fibrosis lung bacterial communities
van der Gast, C. J., Walker, A. W., Stressmann, F. A., Rogers, G. B., Scott, P., Daniels, T. W., Carroll, M. P., Parkhill, J., & Bruce, K. D. (2011) · The ISME Journal · doi:10.1038/ismej.2010.175 · Cited by 266
Concentration-dependent activity in natural environments
Bernier, S. P., & Surette, M. G. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00020 · Cited by 260
Self-citationChanges in cystic fibrosis airway microbiota at pulmonary exacerbation
Carmody, L. A., Zhao, J., Schloss, P. D., Petrosino, J. F., Murray, S., Young, V. B., Li, J. Z., & LiPuma, J. J. (2013) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201211-107oc · Cited by 239
Stearns, J. C., Davidson, C. J., McKeon, S., Whelan, F. J., Fontes, M. E., Schryvers, A. B., Bowdish, D. M. E., Kellner, J. D., & Surette, M. G. (2015) · The ISME Journal · doi:10.1038/ismej.2014.250 · Cited by 234
Self-citationInflammation and Airway Microbiota during Cystic Fibrosis Pulmonary Exacerbations
Zemanick, E. T., Harris, J. K., Wagner, B. D., Robertson, C. E., Sagel, S. D., Stevens, M. J., Accurso, F. J., & Laguna, T. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062917 · Cited by 180
“However, the contribution of anaerobes to PEx and lung disease in CF is incompletely understood [14–17].”
BackgroundCarmody, L. A., Zhao, J., Kalikin, L. M., LeBar, W., Simon, R. H., Venkataraman, A., Schmidt, T. M., Abdo, Z., Schloss, P. D., & LiPuma, J. J. (2015) · Microbiome · doi:10.1186/s40168-015-0074-9 · Cited by 135
“Studies employing culture-independent analyses have shown that CF airways typically harbor complex microbial communities comprised of numerous bacterial species, particularly during the early and intermediate stages of lung disease [1-9].”
Price, K. E., Hampton, T. H., Gifford, A. H., Dolben, E. L., Hogan, D. A., Morrison, H. G., Sogin, M. L., & O’Toole, G. A. (2013) · Microbiome · doi:10.1186/2049-2618-1-27 · Cited by 135
Quinn, R. A., Lim, Y. W., Maughan, H., Conrad, D., Rohwer, F., & Whiteson, K. L. (2014) · mBio · doi:10.1128/mbio.00956-13 · Cited by 115
Dixon, E. F., & Hall, R. A. (2015) · Cellular Microbiology · doi:10.1111/cmi.12490 · Cited by 73
Metadata
- Authors
- Sibley, C. D., Parkins, M. D., Rabin, H. R., Duan, K., Norgaard, J. C., & Surette, M. G.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2008-09-30
- Volume
- 105
- Issue
- 39
- Pages
- 15070-15075
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2095566399
- Cited by
- 312
- References
- 32
- FWCI
- 18.92
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.